Tag: pharmaceuticals
New FDA Guidance Will Make It Easier To Approve CBD-Based Medicines
Australia’s MGC Pharma $15m funding deal with US Mercer Street Global Opportunity Fund
Anecdotal Reports Versus Clinical Research on Cannabis
DEA Proposes Hemp And CBD Rules To Comply With Crop’s Legalization
Katikati medicinal cannabis firm granted commercial licence
Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact
Cannabinoids may affect activity of other pharmaceuticals
FDA approves GW Pharmaceuticals’ cannabis drug for new indication
Stockhead: MGC Pharma expands footprint with cannabis clinic acquisition
MGC Pharma granted medicinal cannabis import licence
GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug
The Numbers Are Public & GW Executives Are Raking In The Cash
Federal Reserve Bank Highlights Economic Potential And Health Impacts Of Marijuana Legalization
A Cancer Survivor’s Guide to Using Cannabis to Cope With Chemotherapy
GW Pharmaceuticals loses $8 million over last quarter
GW Pharma trims loss to $8 million, warns virus could hit sales
High Times Greats: Terry Southern
CBD Prescription Drug Is No Longer A Federally Controlled Substance
CBD Prescription Drug Is No Longer A Federally Controlled Substance, DEA Says
GWPH Stock Recovers on Regained Sativex Rights
WHO Delays Rescheduling Vote Yet Again – Now We Are Told “Maybe December 2020?”
Nano CBD – Marketing Ploy or the Real Deal?
GW Pharmaceuticals regains exclusive commercialisation rights to Sativex® (nabiximols) in the UK from Bayer
How Weed Is Helping Opioid Users Beat Addiction | VICE | United States
Australia: MGC to distribute medical cannabis in South America
British Scientists Studying Anti-psychotic Effects of ‘Charlotte’s Web’ Style Medical Marijuana – The Ring of Fire Network
GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales
GW Pharma beats analyst projections with $108M in Q4 sales thanks to CBD drug
GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy
Indiva Adds White-Label Partnership and Announces Unsecured Convertible Debenture Financing
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds
Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up
NHS approves two cannabis-based medicines for children suffering from epilepsy
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appoints Strategic Advisor, Advances Tech Platform as Alternative to Smoking and Vaping
420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
Lesotho: Two Senior Health Ministry Officials Overseeing Cannabis Industry Licensing Linked To Company Planning To Produce Medicinal Cannabis In The Country
GW Pharma Posts CBD Drug for Epilepsy Sales of $86 Million in Q3
420 with CNW – Two Studies Show Marijuana is Helping Patients Avoid Opioids
Two More Studies Show Patients Are Replacing Prescription Painkillers With Marijuana
USA | Even without proof, CBD is finding a niche as a cure-all
JAMAICA | Cannabis class at UWI Jamaica campus today
This high-tech, grow-it-yourself medical cannabis kit is as easy as using an app
Singapore: ‘Scientific evidence’ to guide cannabis law
Cannabis An Alternative Treatment to Pharmaceuticals .Check out this video
Colorado to allow CBD prescriptions.
A Marijuana Market Most Investors Aren’t Thinking About — The Motley Fool
A Look At The Cannabis Movement In The UK
UK| Medical cannabis use could be legal in Channel Islands – BBC News
High time: introducing the Guardian’s new cannabis column for grownups | Society | The Guardian
Hippy dream now a billion-dollar industry with California set to legalise cannabis | US news | The Guardian
This Is the Biggest Marijuana Story of the Year, in Case You Missed It — The Motley Fool| USA
The user guide to legal pot in all Canada’s provinces, territories | Financial Post
Dr David Potter. The Biology And Benefits Of Cannabis – CLEAR
Burgeoning Cannabis Industry Has a Growing Need for Scientists
First medical, then recreational: Montreal marijuana plant opens
Legalizing Recreational Marijuana in Colorado Reversed a 14-Year Trend of Rising Opioid-Related Deaths
13 Must-Know Facts for Cannabis Beginners
Why moms should put down the wine and pick up the weed
Medicanja launches six ganja based products|Jamaica
In the legal weed industry, women are more likely to be executives — Quartz
Science, Women and Cannabis Make a Healthy, Successful Combination
Australian Biotech Company Wants to Treat Autism Symptoms With Cannabis | Leafly
5 Australian Marijuana Stocks You Can Trade OTC | Seeking Alpha
UK Patients Won’t Benefit From GW Pharma’s Expansion | Marijuana
New York doubles the number of licensed medical marijuana distributors | Crain’s New York Business
Cannabis-derived medication shows promise in Phase 2 clinical study | The Brain Tumour Charity
Cannabis Medicine Offers Seniors A New Way To Grow Old | Cannabis Now
